News about obesity: events, facts and developments on tafs uz.
4 stories
Endocrinologist Elizaveta Zolotova explained that the popular term 'cortisol belly' has nothing to do with stress in 95% of cases: belly growth is linked to an overall excess of fat tissue, while the rare hormonal pathology occurs in about 1% of people with obesity.
Otabek YusupovDmitry Nikityuk, director of the Federal Research Center for Nutrition and Biotechnology, reported that the highest obesity rate among Russian adults is in the Jewish Autonomous Region (more than 30%), and the lowest is in the Chukotka Autonomous Area (6.6%).
Otabek YusupovDipiaron, a capsule drug developed at the Volgograd State Medical University, has passed the first phase of clinical trials. In July, the Ministry of Health authorized the second phase involving 308 patients. The drug acts on the GPR119 receptor and, according to the developers, preserved pancreatic cells in animal experiments. If the research is successful, the drug could reach the market no earlier than 2028.
Aziz KarimovA cross-party health committee called the plan to provide Mounjaro to 220,000 people by 2028 'inadequate': it covers only about 6% of the 2.8 million eligible patients. MPs pointed to a 'two-tier system', growth in private purchases and the black market, urged learning from private digital services and stronger action against illegal drug sales.
Sevara Azamova
